EA201891349A1 - Производные гексагидропиразинотриазинона в качестве ингибиторов киназы - Google Patents

Производные гексагидропиразинотриазинона в качестве ингибиторов киназы

Info

Publication number
EA201891349A1
EA201891349A1 EA201891349A EA201891349A EA201891349A1 EA 201891349 A1 EA201891349 A1 EA 201891349A1 EA 201891349 A EA201891349 A EA 201891349A EA 201891349 A EA201891349 A EA 201891349A EA 201891349 A1 EA201891349 A1 EA 201891349A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
hexagidropyrazinotriasinon
kinase inhibitors
pi4kiiiβ
hexahydropyrazino
Prior art date
Application number
EA201891349A
Other languages
English (en)
Other versions
EA037559B1 (ru
Inventor
Хелен Трейси Хорсли
Ричард Джон Мирс
Джуди Шарлотта Нойсс
Джеймс Томас Рюберсон
Original Assignee
Юсб Байофарма Спрл
Католике Университейт Лёвен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юсб Байофарма Спрл, Католике Университейт Лёвен filed Critical Юсб Байофарма Спрл
Publication of EA201891349A1 publication Critical patent/EA201891349A1/ru
Publication of EA037559B1 publication Critical patent/EA037559B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

В заявке описана серия производных 1,2,6,7,9,9a-гексагидропиразино[1,2-d][1,2,4]триазин-4-она, замещенных в положении 8 необязательно замещенной конденсированной бициклической гетероароматической группой и в положении 3 рядом функциональных групп, являющихся селективными ингибиторами активности фосфатидилинозит-4-киназы IIIβ (PI4KIIIβ), полезных для лечения и/или предупреждения различных заболеваний человека, включая воспалительные, аутоиммунные и онкологические нарушения; вирусные заболевания и малярию; и отторжение трансплантата органа и клеток.
EA201891349A 2015-12-10 2016-12-08 Производные гексагидропиразинотриазинона в качестве ингибиторов киназы EA037559B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1521767.2A GB201521767D0 (en) 2015-12-10 2015-12-10 Therapeutic agents
PCT/EP2016/080168 WO2017097871A1 (en) 2015-12-10 2016-12-08 Hexahydropyrazinotriazinone derivatives as kinase inhibitors

Publications (2)

Publication Number Publication Date
EA201891349A1 true EA201891349A1 (ru) 2019-01-31
EA037559B1 EA037559B1 (ru) 2021-04-14

Family

ID=55274503

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891349A EA037559B1 (ru) 2015-12-10 2016-12-08 Производные гексагидропиразинотриазинона в качестве ингибиторов киназы

Country Status (10)

Country Link
US (1) US10450320B2 (ru)
EP (1) EP3386984B1 (ru)
JP (1) JP6775019B2 (ru)
CN (1) CN108699064B (ru)
BR (1) BR112018011656A2 (ru)
CA (1) CA3007975A1 (ru)
EA (1) EA037559B1 (ru)
ES (1) ES2894680T3 (ru)
GB (1) GB201521767D0 (ru)
WO (1) WO2017097871A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112752761B (zh) 2018-08-21 2024-03-29 杏林制药株式会社 双环杂芳族环衍生物
AR117472A1 (es) 2018-12-21 2021-08-11 Celgene Corp Inhibidores de tienopiridina de ripk2

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2665277T3 (es) 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Análogos de purina y su uso como agentes inmunosupresores
EP2417138B1 (en) * 2009-04-09 2019-11-27 Merck Sharp & Dohme Corp. Pyrazolo[1, 5-a]pyrimidine derivatives as mtor inhibitors
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
GB201114212D0 (en) 2011-08-18 2011-10-05 Ucb Pharma Sa Therapeutic agents
GB201115665D0 (en) 2011-09-09 2011-10-26 Univ Leuven Kath Autoimmune and inflammatory disorder therapy
GB201119401D0 (en) 2011-11-10 2011-12-21 Ucb Pharma Sa Therapeutic agents
GB201217704D0 (en) 2012-10-03 2012-11-14 Ucb Pharma Sa Therapeutic agents
KR102215490B1 (ko) * 2012-12-20 2021-02-15 유씨비 바이오파마 에스알엘 치료 활성 피라졸로-피리미딘 유도체
GB201410816D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
GB201410815D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
GB201410817D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents

Also Published As

Publication number Publication date
JP6775019B2 (ja) 2020-10-28
EP3386984B1 (en) 2021-08-11
ES2894680T3 (es) 2022-02-15
WO2017097871A1 (en) 2017-06-15
GB201521767D0 (en) 2016-01-27
EP3386984A1 (en) 2018-10-17
EA037559B1 (ru) 2021-04-14
CA3007975A1 (en) 2017-06-15
CN108699064A (zh) 2018-10-23
CN108699064B (zh) 2021-09-14
US20180362532A1 (en) 2018-12-20
JP2019502678A (ja) 2019-01-31
BR112018011656A2 (pt) 2018-12-04
US10450320B2 (en) 2019-10-22

Similar Documents

Publication Publication Date Title
EA201890827A1 (ru) Конденсированные производные пиразола в качестве ингибиторов киназы
CL2016001895A1 (es) Compuestos
CY1119588T1 (el) Εκλεκτικοι αναστολεις pi3κ δελτα
BR112016029630A2 (pt) derivados heteroaromáticos bicíclicos fundidos como inibidores de inibidores de cinase
BR112019010222A8 (pt) Polimorfos de sepiapterina e sais dos mesmos
EA201592199A1 (ru) Производные бипиразола в качестве ингибиторов jak
CY1120415T1 (el) Θεραπευτικα δραστικα παραγωγα πυραζολο-πυριμιδινης
BR112019005969A2 (pt) inibidores seletivos de jak1 inovadores e usos dos mesmos
CY1119063T1 (el) Υποκατασταθεισες δικυκλικες διυδροπυριμιδινονες και η χρηση τους ως αναστολεις της δραστικοτητας ελαστασης ουδετεροφιλων
UY36265A (es) “derivados de pirrolo[2,3-d]pirimidina”.
CO2018013803A2 (es) 1h-pirazolo[4,3-b]piridinas como inhibidores de pde1
BR112016029632A2 (pt) derivados heteroaromáticos bicíclicos fundidos como inibidores de cinase
EA201890626A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНОВЫЕ АНТИБАКТЕРИАЛЬНЫЕ СОЕДИНЕНИЯ
CL2019002605A1 (es) Formulaciones que contienen proteínas de unión pd-1 y métodos de fabricación de las mismas.
ECSP17010481A (es) Novedosas pirimidinas 2,5-sustituidas
FR22C1058I2 (fr) Formulation de comprimé de 2-fluoro-n-méthyl-4-[7-(quinoline -6-ylméthyl) imidazo[1,2-b][1,2,4]triazine -2-yl]benzamide
HK1247923A1 (zh) 可用作哺乳動物酪氨酸激酶ror1活性抑制劑的2-苯基-3h-咪唑並[4，5-b]吡啶衍生物
TR201901338T4 (tr) Kinaz İnhibitörleri Olarak Pirazolo-Piridin Türevleri
CY1121933T1 (el) Υποκατεστημενες δικυκλικες διυδροπυριμιδινονες και χρηση αυτων ως αναστολεις δραστικοτητας ελαστασης ουδετεροφιλου
ECSP17010482A (es) Novedosas pirimidinas 2,5-sustituidas
CO2017010621A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
CL2016000939A1 (es) Compuestos derivados de pirimidina con actividad inhibidora de syk uso en el tratamiento de una condición inmune, enfermedades inflamatorias, trastornos alérgicos, lupus eritomatosos, epoc, bronquitis, rinitis alérgica, asma, entre otras composición farmacéutica que los comprende.
EA201791294A1 (ru) 7-(МОРФОЛИНИЛ)-2-(N-ПИПЕРАЗИНИЛ)МЕТИЛТИЕНО[2,3-c]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ
EA201891349A1 (ru) Производные гексагидропиразинотриазинона в качестве ингибиторов киназы
EA202091691A1 (ru) ТВЕРДЫЕ ФОРМЫ ЗАМЕЩЕННЫХ 5,6-ДИГИДРО-6-ФЕНИЛБЕНЗО[f]ИЗОХИНОЛИН-2-АМИНОВЫХ СОЕДИНЕНИЙ